{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:16:35Z","timestamp":1771956995523,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s10072-022-06182-w","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T06:02:24Z","timestamp":1654495344000},"page":"5165-5168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["SARS-CoV-2 vaccination, Parkinson\u2019s disease, and other movement disorders: case series and short literature review"],"prefix":"10.1007","volume":"43","author":[{"given":"Gabriele","family":"Imbalzano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Ledda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Alberto","family":"Artusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Romagnolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Montanaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Giorgio","family":"Rizzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Lopiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2939-343X","authenticated-orcid":false,"given":"Maurizio","family":"Zibetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"6182_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10072-021-05662-9","volume":"43","author":"RK Garg","year":"2022","unstructured":"Garg RK, Paliwal VK (2022) Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci 43:3\u201340. https:\/\/doi.org\/10.1007\/s10072-021-05662-9","journal-title":"Neurol Sci"},{"key":"6182_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/JPD-212573","volume":"11","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Trenkwalder C, Sanchez-Ferro A, Kalia LV, Alcalay R, Chiang HL, Kang UJ, Goetz C, Brundin P, Papa SM (2021) COVID-19 vaccination for persons with Parkinson\u2019s disease: light at the end of the tunnel? J Parkinsons Dis 11:3\u20138. https:\/\/doi.org\/10.3233\/JPD-212573","journal-title":"J Parkinsons Dis"},{"key":"6182_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/mds.28104","volume":"35","author":"A Antonini","year":"2020","unstructured":"Antonini A, Leta V, Teo J, Chaudhuri KR (2020) Outcome of Parkinson\u2019s disease patients affected by COVID-19. Mov Disord 35:905\u2013908. https:\/\/doi.org\/10.1002\/mds.28104","journal-title":"Mov Disord"},{"key":"6182_CR4","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/ene.15217","volume":"29","author":"SA Schneider","year":"2021","unstructured":"Schneider SA, Hennig A, Martino D (2021) Relationship between COVID-19 and movement disorders: a narrative review. Eur J Neurol 29:1243\u20131253. https:\/\/doi.org\/10.1111\/ene.15217","journal-title":"Eur J Neurol"},{"key":"6182_CR5","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/mds.28772","volume":"36","author":"R Erro","year":"2021","unstructured":"Erro R, Buonomo AR, Barone P, Pellecchia MT (2021) Severe dyskinesia after administration of SARS-CoV2 mRNA vaccine in Parkinson\u2019s disease. Mov Disord 36:2219. https:\/\/doi.org\/10.1002\/mds.28772","journal-title":"Mov Disord"},{"key":"6182_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/mds.28851","volume":"37","author":"C Cosentino","year":"2022","unstructured":"Cosentino C, Torres L, V\u00e9lez M, Nu\u00f1ez Y, S\u00e1nchez D, Armas C, Alvarado M (2022) SARS-CoV-2 vaccines and motor symptoms in Parkinson\u2019s disease. Mov Disord 37:233. https:\/\/doi.org\/10.1002\/mds.28851","journal-title":"Mov Disord"},{"key":"6182_CR7","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/mds.28796","volume":"36","author":"E Matar","year":"2021","unstructured":"Matar E, Manser D, Spies JM, Worthington JM, Parratt KL (2021) Acute hemichorea-hemiballismus following COVID-19 (AZD1222) vaccination. Mov Disord 36:2714\u20132715. https:\/\/doi.org\/10.1002\/mds.28796","journal-title":"Mov Disord"},{"key":"6182_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10072-021-05763-5","volume":"43","author":"DW Ryu","year":"2022","unstructured":"Ryu DW, Lim EY, Cho AH (2022) A case of hemichorea following administration of the Pfizer-BioNTech COVID-19 vaccine. Neurol Sci 43:771\u2013773. https:\/\/doi.org\/10.1007\/s10072-021-05763-5","journal-title":"Neurol Sci"},{"key":"6182_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/14760584.2021.1911653","volume":"20","author":"Y Shi","year":"2021","unstructured":"Shi Y, Guo M, Yang W, Liu S, Zhu B, Yang L, Yang C, Liu C (2021) Is SARS-CoV-2 vaccination safe and effective for elderly individuals with neurodegenerative diseases? Expert Rev Vaccines 20:375\u2013383. https:\/\/doi.org\/10.1080\/14760584.2021.1911653","journal-title":"Expert Rev Vaccines"},{"key":"6182_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:19. https:\/\/doi.org\/10.1186\/s40035-015-0042-0","journal-title":"Transl Neurodegener"},{"key":"6182_CR11","doi-asserted-by":"publisher","first-page":"15014","DOI":"10.1038\/npjparkd.2015.14","volume":"1","author":"F Brugger","year":"2015","unstructured":"Brugger F, Erro R, Balint B et al (2015) Why is there motor deterioration in Parkinson\u2019s disease during systemic infections-a hypothetical view. NPJ Parkinsons Dis 1:15014. https:\/\/doi.org\/10.1038\/npjparkd.2015.14","journal-title":"NPJ Parkinsons Dis"},{"key":"6182_CR12","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","volume":"398","author":"APS Munro","year":"2021","unstructured":"Munro APS, Janani L, Cornelius V,: COV-BOOST study group, et al (2021) Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet 398:2258\u20132276. https:\/\/doi.org\/10.1016\/S0140-6736(21)02717-3","journal-title":"Lancet"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06182-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06182-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06182-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T04:11:57Z","timestamp":1660709517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06182-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["6182"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06182-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"assertion":[{"value":"1 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that the approval of an institutional review board was not required for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval."}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}